BOK and cancer: Very interestingly, E.A./CDDP combination completely blunted Bok expression in the cancer cells treated, suggesting that this Bcl-2 ovarian killer, which controlled a non-canonical apoptosis pathway, is not involved in the death process-induced by the combination.